Triebel Frederic Joseph Daniel 3 Filing

From the Filing

EDGAR Filing Documents for 0001193125-26-135613 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 3 - Initial statement of beneficial ownership of securities: SEC Accession No. 0001193125-26-135613 Filing Date 2026-04-01 Accepted 2026-04-01 06:17:18 Documents 1 Period of Report 2026-03-18 Document Format Files Seq Description Document Type Size 1 3 ownership.html 3 1 3 ownership.xml 3 7082 Complete submission text file 0001193125-26-135613.txt 8706 Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003 IMMUTEP Ltd ( Issuer ) CIK : 0001506184 (see all company filings) EIN. : 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address LEVEL 32, 264 GEORGE STREET SYDNEY, NSW Australia 2000 Business Address Triebel Frederic Joseph Daniel ( Reporting ) CIK : 0002121790 (see all company filings) Type: 3 | Act: 34 | File No.: 001-35428 | Film No.: 26824572